当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第27期
编号:13106097
新型丝氨酸蛋白酶Corin在心血管病中的研究进展(5)
http://www.100md.com 2017年9月25日 《中国医药导报》 2017年第27期
     [24] Zhang SM,Shen JX,Li H,et al. Association between serum corin levels and risk of acute myocardial infarction [J]. Clinica Chimica Acta,2016,452:134-137.

    [25] Zhou X,Chen J,Zhang Q,et al. Prognostic Value of Plasma Soluble Corin in Patients With Acute Myocardial Infarction [J]. J Am Coll Cardiol,2016,67(17):2008-2014.

    [26] Chen F,Xia Y,Liu Y,et al. Increased plasma corin levels in patients with atrial fibrillation [J]. Clin Chim Acta,2015,447:79-85.

    [27] Fang C,Shen L,Dong L,et al. Reduced urinary corin levels in patients with chronic kidney disease [J]. Clin Sci(Lond),2013,124(12):709-717.

    [28] Polzin D,Kaminski HJ,Kastner C,et al. Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases [J]. Kidney Int,2010,78(7):650-659.

    [29] Cui Y,Wang W,Dong N,et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy [J]. Nature,2012,484(7393):246-250.

    (收稿日期:2017-06-22 本文編辑:程 铭), http://www.100md.com(冯模强 余朝萍 赵佐芳)
上一页1 2 3 4 5